Cargando…
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
Oligonucleotide-based therapeutics have become a reality, and are set to transform management of many diseases. Nevertheless, the modulatory activities of these molecules on immune responses remain incompletely defined. Here, we show that gene targeting 2′-O-methyl (2′OMe) gapmer antisense oligonucl...
Autores principales: | Alharbi, Arwaf S, Garcin, Aurélie J, Lennox, Kim A, Pradeloux, Solène, Wong, Christophe, Straub, Sarah, Valentin, Roxane, Pépin, Geneviève, Li, Hong-Mei, Nold, Marcel F, Nold-Petry, Claudia A, Behlke, Mark A, Gantier, Michael P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367172/ https://www.ncbi.nlm.nih.gov/pubmed/32544249 http://dx.doi.org/10.1093/nar/gkaa523 |
Ejemplares similares
-
Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides
por: Valentin, Roxane, et al.
Publicado: (2021) -
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021) -
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
por: Prakash, Thazha P, et al.
Publicado: (2019) -
Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides
por: Yoshida, Tokuyuki, et al.
Publicado: (2022) -
Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
por: Genna, Vito, et al.
Publicado: (2023)